The International Union of Basic and Clinical Pharmacology (IUPHAR) is a voluntary, non-profit association representing the interests of scientists in pharmacology-related fields to facilitate Better Medicines through Global Education and Research around the world.
The Federation of American Societies for Experimental Biology (FASEB), based in Rockville, Maryland, is a non-profit organization of scientific societies in the United States. With a focus on the biological and biomedical sciences, the federation represents scientists in such fields as anatomy, physiology, immunology, biochemistry, molecular biology, toxicology, genetics, and nutrition.
Andarine is a selective androgen receptor modulator (SARM) which was developed by GTX, Inc for the treatment of conditions such as muscle wasting, osteoporosis, and benign prostatic hypertrophy (BPH), using the nonsteroidal antiandrogen bicalutamide as a lead compound. Development of andarine for all indications has been discontinued, in favor of the structurally related and improved compound enobosarm.
Bernard Beryl Brodie was a founding scientist in the area of biochemical and neurochemical pharmacology whose work in the 1940s and 1950s had great impact. He was a major figure in the fields of drug metabolism and drug therapy, studying how the absorption and interactions of drugs in the body. Brodie helped to found and lead the Laboratory of Chemical Pharmacology at the National Heart Institute in Bethesda, Maryland, one of the National Institutes of Health. He was a member of the United States National Academy of Sciences.
The Journal of Pharmacology and Experimental Therapeutics is a peer-reviewed scientific journal covering pharmacology. It has been published since 1909 by the American Society for Pharmacology and Experimental Therapeutics (ASPET). The journal publishes mainly original research articles, and accepts papers covering all aspects of the interactions of chemicals with biological systems.
Michael Cowley FTSE is an Australian physiologist. He is best known for his mapping of the neural circuits involved in metabolism and obesity and diabetes treatment. He is a professor in the Department of Physiology at Monash University in the Faculty of Biomedical and Psychological Sciences. He is also a director of the Australian diabetes drug development company, Verva Inc, and director of the Monash Obesity & Diabetes Institute] (modi).
Drug Metabolism and Disposition is a peer-reviewed scientific journal covering the fields of pharmacology and toxicology. It was established in 1973 and is published monthly by the American Society for Pharmacology and Experimental Therapeutics. The journal publishes articles on in vitro and in vivo studies of the metabolism, transport, and disposition of drugs and environmental chemicals, including the expression of drug-metabolizing enzymes and their regulation. As of 2022, the editor-in-chief is XinXin Ding.
Urs Albert Meyer is a Swiss physician-scientist and clinical pharmacologist.
Philip Needleman was an American medical researcher, pharmaceutical industry executive and leader and philanthropist.
Salomon Zender Langer is an Argentinian pharmacologist whose family had fled from Poland to Argentina in the early 1930s and were thus saved from the Holocaust during the Second World War.
Marion Sewer (1972-2016) was a pharmacologist and professor at the University of California, San Diego's Skaggs School of Pharmacy and Pharmaceutical Sciences known for her research on steroid hormone biogenesis and her commitment to increasing diversity in science. Much of her research centered around cytochrome P450, a family of enzymes involved in the conversion of cholesterol into steroid hormones. She died unexpectedly at the age of 43 from a pulmonary embolism on January 28, 2016, while traveling through the Detroit airport.
Dixon Miles Woodbury (1921–1991) was an American epilepsy researcher and distinguished professor of Physiology and Pharmacology at the University of Utah School of Medicine. His research helped clarify the causes of seizure disorders and the mechanisms of anticonvulsant drugs. He published over 300 scientific articles and edited several books on epilepsy, including the first two volumes of Antiepileptic Drugs. His awards include the John Jacob Abel Award from the American Society for Pharmacology and Experimental Therapeutics (ASPET); the Epilepsy Research Award from the International League Against Epilepsy; Research Career Award from the National Institutes of Health; and William G. Lennox Award for outstanding research in epilepsy from the American Epilepsy Society.
Namandjé N. Bumpus is an American pharmacologist who serves as the Principal Deputy Commissioner and Acting Chief Scientist of the Food and Drug Administration. She was previously director of the department of pharmacology and molecular sciences at Johns Hopkins University School of Medicine, where she holds the E.K. Marshall and Thomas H. Maren professorship in pharmacology. Bumpus is known for her research on the metabolism of antiviral drugs used to treat HIV-1 and how genetic variations in drug-processing enzymes may impact these drugs' efficacy. Bumpus received a Presidential Early Career Award for Scientists and Engineers in 2016. The Food and Drug Administration’s top scientist Namandjé Bumpus has assumed the role of principal deputy commissioner when longtime agency leader Janet Woodcock retired from that role in January 2024.
Jin Zhang is a Chinese-American biochemist. She is a professor of pharmacology, chemistry and biochemistry, and biomedical engineering at the University of California, San Diego.
Robert J. Cousins is an American nutritional biochemist who has researched the metabolism of heavy metals, especially zinc. He has served as president of the Federation of American Societies for Experimental Biology (FASEB) and the American Society for Nutrition (ASN). He was recognized with membership in the National Academy of Sciences in 2000 and served as editor of the Annual Review of Nutrition for ten years.
Lee Limbird is a pharmacologist, Dean of the School of Natural Science, Mathematics and Business & Professor in the Department of Life and Physical Sciences at Fisk University, Nashville, Tennessee.
Eva King Killam was a research pharmacologist who studied the activity of drugs on the brain and behavior, developing animal models for epilepsy and opiate dependence.
John Stephen Lazo is an American pharmacologist noted for his work discovering the fundamental mechanisms of action of small molecule therapeutics and the factors that confer drug resistance. He is a professor emeritus of pharmacology at University of Virginia.
Collen Masimirembwa is a biomedical pharmacologist from Zimbabwe who holds the position of distinguished professor of clinical pharmacology at the University of Cape Town, and president and chief scientific officer at the African Institute of Biomedical Science and Technology (AiBST). His research in Africa has contributed to the field of pharmacogenetics, particularly in understanding the genetic diversity and drug response of African populations. He is associated with the African Academy of Sciences (AAS) and the Zimbabwe Academy of Sciences (ZAS), and was honoured with the HUGO Africa Award in 2018.
